People · Operator
Named in public records as an officer, director or promoter · active 2022–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ubivac, Inc. | — | Biotechnology | Seed | $2.6M | $759K | 2022 |
Jon A. Wigginton, M.D. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Jon A. Wigginton, M.D. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hong-Ming Hu, Ph.D. | 1 | 1 |
| Bernard A. Fox, III | 1 | 1 |
| Bernard Fox, Ph.D. | 1 | 1 |
| Sung Poblete, R.N., Ph.D. | 1 | 1 |
| Nancy Lime | 1 | 1 |
| Bernard A. Fox, Ph.D. | 1 | 1 |
| Steve A. Buhaly | 1 | 1 |
| Bernard A. Fox, MBA | 1 | 1 |
| Nancy A. Lime | 1 | 1 |
| Hong-Ming A. Hu, Ph.D. | 1 | 1 |
| Bernard A. Fox III, MBA | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.